SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-488093"
 

Sökning: id:"swepub:oai:DiVA.org:uu-488093" > Grey matter morphol...

Grey matter morphology in women with premenstrual dysphoric disorder treated with a selective progesterone receptor modulator.

Kaltsouni, Elisavet (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Neuropsykofarmakologi
Dubol, Manon (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Neuropsykofarmakologi
Wikström, Johan, 1964- (författare)
Uppsala universitet,Radiologi
visa fler...
Lanzenberger, Rupert (författare)
Sundström Poromaa, Inger, 1964- (författare)
Uppsala universitet,Reproduktiv hälsa
Comasco, Erika, 1982- (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Neuropsykofarmakologi
visa färre...
 (creator_code:org_t)
Elsevier, 2022
2022
Engelska.
Ingår i: European Neuropsychopharmacology. - : Elsevier. - 0924-977X .- 1873-7862. ; 65, s. 35-43
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Premenstrual dysphoric disorder (PMDD) is characterized by severe cyclic mood symptoms emerging in the luteal phase of the menstrual cycle. The variation in progesterone levels and its metabolites during the luteal phase seems critical to the occurrence of PMDD symptoms. Notably, the efficacy of selective progesterone receptor modulator (SPRM) treatment on the mental symptoms of PMDD has been recently demonstrated. In the present study, structural magnetic resonance imaging was used to assess the effects of SPRM treatment, compared with placebo, on grey matter morphology in women with PMDD. In total, 35 women were scanned during the luteal phase, before and after three months of treatment with SPRM or placebo. Symptom severity was assessed using the Daily Record of Severity of Problems (DRSP), while gonadal hormone levels were measured by liquid chromatography-tandem mass spectrometry. Region-of-interest and whole-brain approaches were employed to perform voxel-based morphometry analyses, subcortical volumetric analyses, and surface-based morphometry analyses. No interaction or main effects of treatment and time were observed on grey matter volume and cortical surface measures (cortical thickness, gyrification index, sulcal depth, and fractal dimension). The relationship between change in brain morphology and symptom severity was also explored but no treatment-dependant grey matter structure change was related to symptom severity change. These findings suggest that SPRM treatment does not impart macrostructural changes onto grey matter structure, at least in the short term.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Reproduktionsmedicin och gynekologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Obstetrics, Gynaecology and Reproductive Medicine (hsv//eng)

Nyckelord

Brain
Grey matter
Magnetic resonance imaging
Premenstrual dysphoric disorder
Progesterone
Surface-based morphometry
Voxel-based morphometry
Women

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy